Renal Pelvis Cancer

Renal pelvis cancer is a malignancy arising from the urothelial lining of the renal pelvis — the funnel-shaped hollow space at the center of the kidney where urine collects after being produced, before draining into the ureter and ultimately into the bladder.

The renal pelvis is lined by urothelium, the same cell type that lines the ureters, the urinary bladder, and the proximal urethra. Because of this shared cellular origin, cancers arising in the renal pelvis belong to the broader category of upper tract urothelial carcinoma (UTUC) and share many biological characteristics, risk factors, and treatment principles with ureteral and bladder cancer.

The disease predominantly affects older adults, with a peak incidence in the seventh and eighth decades of life. Men are affected approximately two to three times more frequently than women. 

Urothelial carcinoma (transitional cell carcinoma)

• Urothelial carcinoma accounts for the overwhelming majority of renal pelvis cancers — approximately 90% or more. These tumors are further categorized by grade (low-grade vs. high-grade) and by growth pattern (papillary vs. flat):
  • Low-grade papillary tumors: These tend to have a more indolent behavior with slower progression and lower metastatic potential.
  • High-grade tumors: These behave more aggressively, with a higher likelihood of muscle invasion, regional lymph node spread, and distant metastasis.

Squamous cell carcinoma

• Squamous cell carcinoma of the renal pelvis is uncommon and is associated with chronic mucosal irritation from longstanding kidney stones, recurrent infection, or schistosomiasis in endemic regions. It is typically diagnosed at a more advanced stage and carries a less favorable prognosis than urothelial carcinoma.

Adenocarcinoma

• Primary adenocarcinoma of the renal pelvis is rare and usually arises in the context of chronic inflammatory changes or glandular metaplasia of the urothelium.

Renal pelvis cancer frequently produces symptoms similar to those of other urinary tract conditions — including kidney stones and urinary tract infection — which can lead to delayed diagnosis. In some patients, particularly those with low-grade tumors, symptoms may be absent entirely.

When symptoms occur, they include:

• Blood in the urine (hematuria): Hematuria is the most common presenting symptom, occurring in the majority of patients. It may be visible to the naked eye or detectable only on urinalysis. Any unexplained hematuria in an adult warrants a thorough urological evaluation.
• Flank pain
• Symptoms of urinary tract infection: If tumor-related obstruction promotes bacterial growth in the upper urinary tract, patients may experience fever, chills, and back pain.
• Palpable abdominal or flank mass: Significant hydronephrosis caused by tumor obstruction may result in an enlarged kidney that is palpable on physical examination.
• Unexplained weight loss

Tobacco smoking

• Cigarette smoking is the most important and well-established risk factor for urothelial carcinoma of the renal pelvis. Carcinogens in tobacco are filtered by the kidneys and concentrate in the urine within the renal collecting system, resulting in prolonged mucosal exposure to these substances. The risk is proportional to the duration and intensity of smoking, and it decreases — though does not fully normalize — after cessation.

Aristolochic acid nephropathy

• Chronic exposure to aristolochic acid — a nephrotoxic substance found in certain traditional herbal remedies used in some Asian and Eastern European countries — causes progressive kidney disease and carries a very high lifetime risk of upper tract urothelial carcinoma, including cancer of the renal pelvis.

Lynch syndrome

• Lynch syndrome is the most clinically important hereditary risk factor for upper tract urothelial carcinoma. Genetic testing is often recommended in all patients diagnosed with UTUC who are under the age of 60 or who have a suggestive family history.

Occupational chemical exposures

• Prolonged occupational exposure to aromatic amines, benzidine, beta-naphthylamine, and related compounds — found in rubber, dye, paint, and textile industries — increases the risk of urothelial malignancies.

Prior or concurrent bladder cancer

• Patients with a prior history of bladder cancer or concurrent bladder cancer are at elevated risk for renal pelvis cancer.

Chronic kidney stone disease

• Longstanding nephrolithiasis (kidney stones) with associated chronic mucosal irritation is associated with an increased risk of squamous cell carcinoma of the renal pelvis.

Age and sex

• Renal pelvis cancer predominantly affects adults over 70 years of age. Men are affected approximately two to three times more often than women.

• Smoking cessation is the single most important modifiable measure to reduce the risk of renal pelvis cancer.
• Avoiding aristolochic acid-containing herbal preparations eliminates a known, avoidable carcinogenic exposure.
• Individuals with Lynch syndrome should undergo regular surveillance of the upper urinary tract, in accordance with hereditary cancer surveillance protocols.
• Patients with a prior history of bladder cancer require surveillance of the upper urinary tract at defined intervals during follow-up.